Classic Congenital Adrenal Hyperplasia clinical trials at UCSF

1 research study open to eligible people

Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
open to eligible people ages 1-17
The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic congenital adrenal hyperplasia (CAH).
San Francisco, California and other locations

Last updated: July 2, 2026